Literature DB >> 16448475

Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial.

N Vendt1, H Grünberg, T Tuure, O Malminiemi, E Wuolijoki, V Tillmann, E Sepp, R Korpela.   

Abstract

BACKGROUND: Probiotic bacteria have beneficial effects on the immune system and gastrointestinal tract, but the impacts of their long-term consumption on health and growth in early infancy are not well documented. The aim of this study was to evaluate the influence of Lactobacillus rhamnosus GG (LGG)-enriched formula on growth and faecal microflora during the first 6 months of life in normal healthy infants.
MATERIALS AND METHODS: One hundred and twenty healthy infants (up to 2 months) received LGG-supplemented formula or regular formula in a double-blind, randomized manner until the age of 6 months. Weight, length and head circumference were measured monthly and transformed into standard deviation scores (SDS). Faecal samples were obtained from a random sample of infants (n=25) at entry and at the end of the study.
RESULTS: One hundred and five infants (51 in the LGG group) completed the study. Children receiving LGG-supplemented formula grew better: their changes in their length and weight SDS (DeltaSDS) at the end of the study were significantly higher than those receiving regular formula (0.44+/- 0.37 versus 0.07+/- 0.06, P< 0.01 and 0.44+/- 0.19 versus 0.07+/- 0.06, P< 0.005, respectively). The LGG group had a significant, higher defecation frequency 9.1+/-2.06 versus 8.0+/- 2.8 (P<0.05). More frequent colonization with lactobacilli was found in the LGG group, 91% versus 76% (P<0.05) at the end of the study. CONCLUSIONS Infants fed with LGG-enriched formula grew better than those fed with regular formula. Further studies are necessary to clarify the mechanism of LGG in infant growth.

Entities:  

Mesh:

Year:  2006        PMID: 16448475     DOI: 10.1111/j.1365-277X.2006.00660.x

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  27 in total

Review 1.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

2.  Effect of long-term antibiotic use on weight in adolescents with acne.

Authors:  Despina G Contopoulos-Ioannidis; Catherine Ley; Wei Wang; Ting Ma; Clifford Olson; Xiaoli Shi; Harold S Luft; Trevor Hastie; Julie Parsonnet
Journal:  J Antimicrob Chemother       Date:  2016-01-17       Impact factor: 5.790

Review 3.  Gut Microbiota in Obesity and Undernutrition.

Authors:  Nicolien C de Clercq; Albert K Groen; Johannes A Romijn; Max Nieuwdorp
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

4.  In vivo gut transcriptome responses to Lactobacillus rhamnosus GG and Lactobacillus acidophilus in neonatal gnotobiotic piglets.

Authors:  Anand Kumar; Anastasia N Vlasova; Zhe Liu; Kuldeep S Chattha; Sukumar Kandasamy; Malak Esseili; Xiaoli Zhang; Gireesh Rajashekara; Linda J Saif
Journal:  Gut Microbes       Date:  2014-01-22

Review 5.  Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.

Authors:  Wanping Aw; Shinji Fukuda
Journal:  Semin Immunopathol       Date:  2014-10-22       Impact factor: 9.623

6.  Bifidobacterium longum subsp infantis CECT7210-supplemented formula reduces diarrhea in healthy infants: a randomized controlled trial.

Authors:  Joaquin Escribano; Natalia Ferré; Mariona Gispert-Llaurado; Veronica Luque; Carmen Rubio-Torrents; Marta Zaragoza-Jordana; Isabel Polanco; Francisco M Codoñer; Empar Chenoll; Mireia Morera; Jose Antonio Moreno-Muñoz; Montserrat Rivero; Ricardo Closa-Monasterolo
Journal:  Pediatr Res       Date:  2018-05-02       Impact factor: 3.756

7.  A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids.

Authors:  Mark A Underwood; Nita H Salzman; Stephen H Bennett; Melissa Barman; David A Mills; Angela Marcobal; Daniel J Tancredi; Charles L Bevins; Michael P Sherman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

8.  Vancomycin treatment of infective endocarditis is linked with recently acquired obesity.

Authors:  Franck Thuny; Hervé Richet; Jean-Paul Casalta; Emmanouil Angelakis; Gilbert Habib; Didier Raoult
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

Review 9.  Gut microbiome and metabolic diseases.

Authors:  Shinji Fukuda; Hiroshi Ohno
Journal:  Semin Immunopathol       Date:  2013-11-06       Impact factor: 9.623

10.  Lactobacillus rhamnosus GG Suppresses Meningitic E. coli K1 Penetration across Human Intestinal Epithelial Cells In Vitro and Protects Neonatal Rats against Experimental Hematogenous Meningitis.

Authors:  Sheng-He Huang; Lina He; Yanhong Zhou; Chun-Hua Wu; Ambrose Jong
Journal:  Int J Microbiol       Date:  2008-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.